 | • レポートコード：20QY06-07075 • 出版社/出版日：QYResearch / 2020年6月2日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥576,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥864,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,152,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、線維筋痛症治療のグローバル市場について種類別（抗うつ薬、抗けいれん薬、筋弛緩薬、麻薬性鎮痛薬、非麻薬性鎮痛薬）、用途別（病院薬局、クリニック薬局、小売ドラッグストア、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・線維筋痛症治療市場の概要 ・世界の主要地域別線維筋痛症治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の線維筋痛症治療市場規模2015-2026：種類別（抗うつ薬、抗けいれん薬、筋弛緩薬、麻薬性鎮痛薬、非麻薬性鎮痛薬） ・世界の線維筋痛症治療市場規模2015-2026：用途別（病院薬局、クリニック薬局、小売ドラッグストア、オンライン薬局） ・線維筋痛症治療の北米市場規模2015-2020 ・線維筋痛症治療のヨーロッパ市場規模2015-2020 ・線維筋痛症治療の中国市場規模2015-2020 ・線維筋痛症治療の日本市場規模2015-2020 ・線維筋痛症治療の東南アジア市場規模2015-2020 ・線維筋痛症治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Eli Lilly and Company、Pfizer、Novartis AG、Allergan、Aptinyx、Prismic Pharmaceuticals、Innovative Med Concepts、Intec Pharma Ltd.、Astellas Pharma、Savella、Sun Pharmaceutical Industries、Mylan NV、Teva Pharmaceutical Industries、Daiichi Sankyo、Forest Pharmaceuticals、Meiji Seika Pharma、Tonix Pharmaceuticals、Theravance Biopharma） ・線維筋痛症治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・線維筋痛症治療の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Fibromyalgia Treatment Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Fibromyalgia Treatment market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Fibromyalgia Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Fibromyalgia Treatment industry.
Based on our recent survey, we have several different scenarios about the Fibromyalgia Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Fibromyalgia Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Fibromyalgia Treatment market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Fibromyalgia Treatment market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Fibromyalgia Treatment market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Fibromyalgia Treatment market. The report also includes nautical information, where it shows Fibromyalgia Treatment market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Fibromyalgia Treatment market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Fibromyalgia Treatment market.
Geographical Analysis:
Based on region, the global Fibromyalgia Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Fibromyalgia Treatment market are
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Segment by Type
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Segment by Application
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Fibromyalgia Treatment market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Fibromyalgia Treatment market.
• The market share of the global Fibromyalgia Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Fibromyalgia Treatment market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Fibromyalgia Treatment market.
1 Fibromyalgia Treatment Market Overview
1.1 Fibromyalgia Treatment Product Scope
1.2 Fibromyalgia Treatment Segment by Type
1.2.1 Global Fibromyalgia Treatment Sales by Type (2020-2026)
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Fibromyalgia Treatment Segment by Application
1.3.1 Global Fibromyalgia Treatment Sales Comparison by Application (2020-2026)
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Fibromyalgia Treatment Market Estimates and Forecasts (2015-2026)
1.4.1 Global Fibromyalgia Treatment Sales Growth Rate (2015-2026)
1.4.2 Global Fibromyalgia Treatment Revenue and Growth Rate (2015-2026)
1.4.3 Global Fibromyalgia Treatment Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Fibromyalgia Treatment Industry Impact
1.5.1 How the Covid-19 is Affecting the Fibromyalgia Treatment Industry
1.5.1.1 Fibromyalgia Treatment Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Fibromyalgia Treatment Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Fibromyalgia Treatment Players to Combat Covid-19 Impact
2 Fibromyalgia Treatment Estimate and Forecast by Region
2.1 Global Fibromyalgia Treatment Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Fibromyalgia Treatment Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Fibromyalgia Treatment Sales Market Share by Region (2015-2020)
2.2.2 Global Fibromyalgia Treatment Revenue Market Share by Region (2015-2020)
2.3 Global Fibromyalgia Treatment Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Fibromyalgia Treatment Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Fibromyalgia Treatment Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Fibromyalgia Treatment Estimates and Projections (2015-2026)
2.4.2 Europe Fibromyalgia Treatment Estimates and Projections (2015-2026)
2.4.3 China Fibromyalgia Treatment Estimates and Projections (2015-2026)
2.4.4 Japan Fibromyalgia Treatment Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Fibromyalgia Treatment Estimates and Projections (2015-2026)
2.4.6 India Fibromyalgia Treatment Estimates and Projections (2015-2026)
3 Global Fibromyalgia Treatment Competition Landscape by Players
3.1 Global Top Fibromyalgia Treatment Players by Sales (2015-2020)
3.2 Global Top Fibromyalgia Treatment Players by Revenue (2015-2020)
3.3 Global Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment as of 2019)
3.4 Global Fibromyalgia Treatment Average Price by Company (2015-2020)
3.5 Manufacturers Fibromyalgia Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Fibromyalgia Treatment Players (Opinion Leaders)
4 Global Fibromyalgia Treatment Market Size by Type
4.1 Global Fibromyalgia Treatment Historic Market Review by Type (2015-2020)
4.1.1 Global Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
4.1.2 Global Fibromyalgia Treatment Revenue Market Share by Type (2015-2020)
4.1.3 Global Fibromyalgia Treatment Price by Type (2014-2020)
4.2 Global Fibromyalgia Treatment Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Fibromyalgia Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Fibromyalgia Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Global Fibromyalgia Treatment Price Forecast by Type (2021-2026)
5 Global Fibromyalgia Treatment Market Size by Application
5.1 Global Fibromyalgia Treatment Historic Market Review by Application (2015-2020)
5.1.1 Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
5.1.2 Global Fibromyalgia Treatment Revenue Market Share by Application (2015-2020)
5.1.3 Global Fibromyalgia Treatment Price by Application (2015-2020)
5.2 Global Fibromyalgia Treatment Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Fibromyalgia Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Fibromyalgia Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Fibromyalgia Treatment Price Forecast by Application (2021-2026)
3 North America Fibromyalgia Treatment Market Facts & Figures
3.2 North America Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
3.3 North America Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
3.4 North America Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
4 Europe Fibromyalgia Treatment Market Facts & Figures
4.2 Europe Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
4.3 Europe Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
4.4 Europe Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
5 China Fibromyalgia Treatment Market Facts & Figures
5.2 China Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
5.3 China Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
5.4 China Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
6 Japan Fibromyalgia Treatment Market Facts & Figures
6.2 Japan Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
6.3 Japan Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
6.4 Japan Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
7 Southeast Asia Fibromyalgia Treatment Market Facts & Figures
7.2 Southeast Asia Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
8 India Fibromyalgia Treatment Market Facts & Figures
8.2 India Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
8.3 India Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
8.4 India Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Fibromyalgia Treatment Business
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Fibromyalgia Treatment Corporation Information
12.1.2 Eli Lilly and Company Fibromyalgia Treatment Business Overview and Total Revenue
12.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly and Company Fibromyalgia Treatment Products Offered
12.1.5 Eli Lilly and Company Recent Development
12.2 Pfizer
12.2.1 Pfizer Fibromyalgia Treatment Corporation Information
12.2.2 Pfizer Fibromyalgia Treatment Business Overview and Total Revenue
12.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Fibromyalgia Treatment Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Fibromyalgia Treatment Corporation Information
12.3.2 Novartis AG Fibromyalgia Treatment Business Overview and Total Revenue
12.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis AG Fibromyalgia Treatment Products Offered
12.3.5 Novartis AG Recent Development
12.4 Allergan
12.4.1 Allergan Fibromyalgia Treatment Corporation Information
12.4.2 Allergan Fibromyalgia Treatment Business Overview and Total Revenue
12.4.3 Allergan Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Allergan Fibromyalgia Treatment Products Offered
12.4.5 Allergan Recent Development
12.5 Aptinyx
12.5.1 Aptinyx Fibromyalgia Treatment Corporation Information
12.5.2 Aptinyx Fibromyalgia Treatment Business Overview and Total Revenue
12.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Aptinyx Fibromyalgia Treatment Products Offered
12.5.5 Aptinyx Recent Development
12.6 Prismic Pharmaceuticals
12.6.1 Prismic Pharmaceuticals Fibromyalgia Treatment Corporation Information
12.6.2 Prismic Pharmaceuticals Fibromyalgia Treatment Business Overview and Total Revenue
12.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Products Offered
12.6.5 Prismic Pharmaceuticals Recent Development
12.7 Innovative Med Concepts
12.7.1 Innovative Med Concepts Fibromyalgia Treatment Corporation Information
12.7.2 Innovative Med Concepts Fibromyalgia Treatment Business Overview and Total Revenue
12.7.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Innovative Med Concepts Fibromyalgia Treatment Products Offered
12.7.5 Innovative Med Concepts Recent Development
12.8 Intec Pharma Ltd.
12.8.1 Intec Pharma Ltd. Fibromyalgia Treatment Corporation Information
12.8.2 Intec Pharma Ltd. Fibromyalgia Treatment Business Overview and Total Revenue
12.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Products Offered
12.8.5 Intec Pharma Ltd. Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Fibromyalgia Treatment Corporation Information
12.9.2 Astellas Pharma Fibromyalgia Treatment Business Overview and Total Revenue
12.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astellas Pharma Fibromyalgia Treatment Products Offered
12.9.5 Astellas Pharma Recent Development
12.10 Savella
12.10.1 Savella Fibromyalgia Treatment Corporation Information
12.10.2 Savella Fibromyalgia Treatment Business Overview and Total Revenue
12.10.3 Savella Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Savella Fibromyalgia Treatment Products Offered
12.10.5 Savella Recent Development
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Fibromyalgia Treatment Corporation Information
12.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Business Overview and Total Revenue
12.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sun Pharmaceutical Industries Fibromyalgia Treatment Products Offered
12.11.5 Sun Pharmaceutical Industries Recent Development
12.12 Mylan NV
12.12.1 Mylan NV Fibromyalgia Treatment Corporation Information
12.12.2 Mylan NV Fibromyalgia Treatment Business Overview and Total Revenue
12.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Mylan NV Fibromyalgia Treatment Products Offered
12.12.5 Mylan NV Recent Development
12.13 Teva Pharmaceutical Industries
12.13.1 Teva Pharmaceutical Industries Fibromyalgia Treatment Corporation Information
12.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Business Overview and Total Revenue
12.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Teva Pharmaceutical Industries Fibromyalgia Treatment Products Offered
12.13.5 Teva Pharmaceutical Industries Recent Development
12.14 Daiichi Sankyo
12.14.1 Daiichi Sankyo Fibromyalgia Treatment Corporation Information
12.14.2 Daiichi Sankyo Fibromyalgia Treatment Business Overview and Total Revenue
12.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Daiichi Sankyo Fibromyalgia Treatment Products Offered
12.14.5 Daiichi Sankyo Recent Development
12.15 Forest Pharmaceuticals
12.15.1 Forest Pharmaceuticals Fibromyalgia Treatment Corporation Information
12.15.2 Forest Pharmaceuticals Fibromyalgia Treatment Business Overview and Total Revenue
12.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Forest Pharmaceuticals Fibromyalgia Treatment Products Offered
12.15.5 Forest Pharmaceuticals Recent Development
12.16 Meiji Seika Pharma
12.16.1 Meiji Seika Pharma Fibromyalgia Treatment Corporation Information
12.16.2 Meiji Seika Pharma Fibromyalgia Treatment Business Overview and Total Revenue
12.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Meiji Seika Pharma Fibromyalgia Treatment Products Offered
12.16.5 Meiji Seika Pharma Recent Development
12.17 Tonix Pharmaceuticals
12.17.1 Tonix Pharmaceuticals Fibromyalgia Treatment Corporation Information
12.17.2 Tonix Pharmaceuticals Fibromyalgia Treatment Business Overview and Total Revenue
12.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Tonix Pharmaceuticals Fibromyalgia Treatment Products Offered
12.17.5 Tonix Pharmaceuticals Recent Development
12.18 Theravance Biopharma
12.18.1 Theravance Biopharma Fibromyalgia Treatment Corporation Information
12.18.2 Theravance Biopharma Fibromyalgia Treatment Business Overview and Total Revenue
12.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Theravance Biopharma Fibromyalgia Treatment Products Offered
12.18.5 Theravance Biopharma Recent Development
13 Fibromyalgia Treatment Manufacturing Cost Analysis
13.1 Fibromyalgia Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Fibromyalgia Treatment
13.4 Fibromyalgia Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Fibromyalgia Treatment Distributors List
14.3 Fibromyalgia Treatment Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Fibromyalgia Treatment Sales (KG) Growth Rate by Type (2020-2026)
Table 2. Global Fibromyalgia Treatment Sales (KG) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Fibromyalgia Treatment Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Fibromyalgia Treatment Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Fibromyalgia Treatment Players to Combat Covid-19 Impact
Table 8. Global Market Fibromyalgia Treatment Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Fibromyalgia Treatment Sales (KG) by Region (2015-2020)
Table 10. Global Fibromyalgia Treatment Sales Market Share by Region (2015-2020)
Table 11. Global Fibromyalgia Treatment Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Fibromyalgia Treatment Revenue Share by Region (2015-2020)
Table 13. Global Fibromyalgia Treatment Sales (KG) Forecast by Region (2021-2026)
Table 14. Global Fibromyalgia Treatment Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Fibromyalgia Treatment Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Fibromyalgia Treatment Revenue Share Forecast by Region (2021-2026)
Table 17. Global Fibromyalgia Treatment (KG) of Key Companies (2015-2020)
Table 18. Global Fibromyalgia Treatment Sales Share by Company (2015-2020)
Table 19. Global Fibromyalgia Treatment Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Fibromyalgia Treatment Revenue Share by Company (2015-2020)
Table 21. Global Fibromyalgia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment as of 2019)
Table 22. Global Fibromyalgia Treatment Average Price (USD/KG) of Key Company (2015-2020)
Table 23. Manufacturers Fibromyalgia Treatment Manufacturing Sites and Area Served
Table 24. Manufacturers Fibromyalgia Treatment Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Fibromyalgia Treatment Players
Table 27. Global Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 28. Global Fibromyalgia Treatment Sales Share by Type (2015-2020)
Table 29. Global Fibromyalgia Treatment Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Fibromyalgia Treatment Price (KG) by Type (2015-2020)
Table 31. Global Fibromyalgia Treatment Sales Share by Type (2021-2026)
Table 32. Global Fibromyalgia Treatment Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Fibromyalgia Treatment Revenue Share by Type (2021-2026)
Table 34. Global Fibromyalgia Treatment Price (KG) by Type (2021-2026)
Table 35. Global Fibromyalgia Treatment Sales (KG) by Application (2015-2020)
Table 36. Global Fibromyalgia Treatment Sales Share by Application (2015-2020)
Table 37. Global Fibromyalgia Treatment Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Fibromyalgia Treatment Price (KG) by Application (2015-2020)
Table 39. Global Fibromyalgia Treatment Sales (KG) by Application (2021-2026)
Table 40. Global Fibromyalgia Treatment Sales Share by Application (2021-2026)
Table 41. Global Fibromyalgia Treatment Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Fibromyalgia Treatment Revenue Share by Application (2021-2026)
Table 43. Global Fibromyalgia Treatment Price (KG) by Application (2021-2026)
Table 44. United States Fibromyalgia Treatment Sales (KG) by Company (2015-2020)
Table 45. United States Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
Table 46. United States Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 47. United States Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 48. United States Fibromyalgia Treatment Sales (KG) by Application (2015-2020)
Table 49. United States Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
Table 50. Europe Fibromyalgia Treatment Sales (KG) by Company (2015-2020)
Table 51. Europe Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
Table 52. Europe Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 53. Europe Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 54. Europe Fibromyalgia Treatment Sales (KG) by Application (2015-2020)
Table 55. Europe Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 56. China Fibromyalgia Treatment Sales (KG) by Company (2015-2020)
Table 57. China Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
Table 58. China Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 59. China Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 60. China Fibromyalgia Treatment Sales (KG) by Application (2015-2020)
Table 61. China Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
Table 62. Japan Fibromyalgia Treatment Sales (KG) by Company (2015-2020)
Table 63. Japan Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
Table 64. Japan Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 65. Japan Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 66. Japan Fibromyalgia Treatment Sales (KG) by Application (2015-2020)
Table 67. Japan Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Fibromyalgia Treatment Sales (KG) by Company (2015-2020)
Table 69. Southeast Asia Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 71. Southeast Asia Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 73. Southeast Asia Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
Table 74. India Fibromyalgia Treatment Sales (KG) by Company (2015-2020)
Table 75. India Fibromyalgia Treatment Sales Market Share by Company (2015-2020)
Table 76. India Fibromyalgia Treatment Sales (KG) by Type (2015-2020)
Table 77. India Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
Table 78. India Fibromyalgia Treatment Sales (KG) by Application (2015-2020)
Table 79. India Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Business Overview
Table 82. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 83. Eli Lilly and Company Fibromyalgia Treatment Product
Table 84. Eli Lilly and Company Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 88. Pfizer Fibromyalgia Treatment Product
Table 89. Pfizer Recent Development
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 93. Novartis AG Fibromyalgia Treatment Product
Table 94. Novartis AG Recent Development
Table 95. Allergan Corporation Information
Table 96. Allergan Description and Business Overview
Table 97. Allergan Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 98. Allergan Fibromyalgia Treatment Product
Table 99. Allergan Recent Development
Table 100. Aptinyx Corporation Information
Table 101. Aptinyx Description and Business Overview
Table 102. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 103. Aptinyx Fibromyalgia Treatment Product
Table 104. Aptinyx Recent Development
Table 105. Prismic Pharmaceuticals Corporation Information
Table 106. Prismic Pharmaceuticals Description and Business Overview
Table 107. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 108. Prismic Pharmaceuticals Fibromyalgia Treatment Product
Table 109. Prismic Pharmaceuticals Recent Development
Table 110. Innovative Med Concepts Corporation Information
Table 111. Innovative Med Concepts Description and Business Overview
Table 112. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 113. Innovative Med Concepts Fibromyalgia Treatment Product
Table 114. Innovative Med Concepts Recent Development
Table 115. Intec Pharma Ltd. Corporation Information
Table 116. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 117. Intec Pharma Ltd. Description and Business Overview
Table 118. Intec Pharma Ltd. Fibromyalgia Treatment Product
Table 119. Intec Pharma Ltd. Recent Development
Table 120. Astellas Pharma Corporation Information
Table 121. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 122. Astellas Pharma Description and Business Overview
Table 123. Astellas Pharma Fibromyalgia Treatment Product
Table 124. Astellas Pharma Recent Development
Table 125. Savella Corporation Information
Table 126. Savella Description and Business Overview
Table 127. Savella Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 128. Savella Fibromyalgia Treatment Product
Table 129. Savella Recent Development
Table 130. Sun Pharmaceutical Industries Corporation Information
Table 131. Sun Pharmaceutical Industries Description and Business Overview
Table 132. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 133. Sun Pharmaceutical Industries Fibromyalgia Treatment Product
Table 134. Sun Pharmaceutical Industries Recent Development
Table 135. Mylan NV Corporation Information
Table 136. Mylan NV Description and Business Overview
Table 137. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 138. Mylan NV Fibromyalgia Treatment Product
Table 139. Mylan NV Recent Development
Table 140. Teva Pharmaceutical Industries Corporation Information
Table 141. Teva Pharmaceutical Industries Description and Business Overview
Table 142. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 143. Teva Pharmaceutical Industries Fibromyalgia Treatment Product
Table 144. Teva Pharmaceutical Industries Recent Development
Table 145. Daiichi Sankyo Corporation Information
Table 146. Daiichi Sankyo Description and Business Overview
Table 147. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 148. Daiichi Sankyo Fibromyalgia Treatment Product
Table 149. Daiichi Sankyo Recent Development
Table 150. Forest Pharmaceuticals Corporation Information
Table 151. Forest Pharmaceuticals Description and Business Overview
Table 152. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 153. Forest Pharmaceuticals Fibromyalgia Treatment Product
Table 154. Forest Pharmaceuticals Recent Development
Table 155. Meiji Seika Pharma Corporation Information
Table 156. Meiji Seika Pharma Description and Business Overview
Table 157. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 158. Meiji Seika Pharma Fibromyalgia Treatment Product
Table 159. Meiji Seika Pharma Recent Development
Table 160. Tonix Pharmaceuticals Corporation Information
Table 161. Tonix Pharmaceuticals Description and Business Overview
Table 162. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 163. Tonix Pharmaceuticals Fibromyalgia Treatment Product
Table 164. Tonix Pharmaceuticals Recent Development
Table . Theravance Biopharma Corporation Information
Table . Theravance Biopharma Description and Business Overview
Table . Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table . Theravance Biopharma Fibromyalgia Treatment Product
Table . Theravance Biopharma Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Fibromyalgia Treatment Distributors List
Table 173. Fibromyalgia Treatment Customers List
Table 174. Market Key Trends
Table 175. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 176. Key Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Fibromyalgia Treatment Product Picture
Figure 2. Global Fibromyalgia Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Fibromyalgia Treatment Market Share by Application in 2020 & 2026
Figure 6. Hospitals Pharmacies Examples
Figure 7. Clinic Pharmacy Examples
Figure 8. Retail Drug Stores Examples
Figure 9. Online Pharmacies Examples
Figure 10. Global Fibromyalgia Treatment Sales (KG) Growth Rate (2015-2026)
Figure 11. Global Fibromyalgia Treatment Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Fibromyalgia Treatment Price Trends Growth Rate (2015-2026) (USD/KG)
Figure 13. Global Fibromyalgia Treatment Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Fibromyalgia Treatment Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Fibromyalgia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Fibromyalgia Treatment Sales (KG) Growth Rate (2015-2026)
Figure 17. Europe Fibromyalgia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Fibromyalgia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Fibromyalgia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Fibromyalgia Treatment Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Fibromyalgia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Fibromyalgia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Fibromyalgia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Fibromyalgia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Fibromyalgia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Fibromyalgia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Fibromyalgia Treatment Players Market Share by Revenue in Fibromyalgia Treatment 2015 & 2019
Figure 28. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Fibromyalgia Treatment Revenue Share by Type (2015-2020)
Figure 30. Global Fibromyalgia Treatment Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Fibromyalgia Treatment Revenue Share by Application (2015-2020)
Figure 32. Global Fibromyalgia Treatment Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 34. United States Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 35. Europe Fibromyalgia Treatment Sales Market Share by Company in 2019
Figure 36. Europe Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 37. Europe Fibromyalgia Treatment Sales Market Share by Application in 2019
Figure 38. China Fibromyalgia Treatment Sales Market Share by Company in 2019
Figure 39. China Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 40. China Fibromyalgia Treatment Sales Market Share by Application in 2019
Figure 41. Japan Fibromyalgia Treatment Sales Market Share by Company in 2019
Figure 42. Japan Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 43. Japan Fibromyalgia Treatment Sales Market Share by Application in 2019
Figure 44. Southeast Asia Fibromyalgia Treatment Sales Market Share by Company in 2019
Figure 45. Southeast Asia Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 46. Southeast Asia Fibromyalgia Treatment Sales Market Share by Application in 2019
Figure 47. India Fibromyalgia Treatment Sales Market Share by Company in 2019
Figure 48. India Fibromyalgia Treatment Sales Market Share by Type in 2019
Figure 49. India Fibromyalgia Treatment Sales Market Share by Application in 2019
Figure 50. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Aptinyx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Prismic Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Innovative Med Concepts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Intec Pharma Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Savella Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Forest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Meiji Seika Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Tonix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Theravance Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Key Raw Materials Price Trend
Figure 69. Manufacturing Cost Structure of Fibromyalgia Treatment
Figure 70. Manufacturing Process Analysis of Fibromyalgia Treatment
Figure 71. Fibromyalgia Treatment Industrial Chain Analysis
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Figure 74. Porter's Five Forces Analysis
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
クラッベ病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Krabbe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Krabbe Disease Treat…- 麻薬性鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Narcotic Analgesics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Narcotic Analgesics marke…
- 非麻薬性鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Non Narcotic Analgesics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non Narcotic Analgesi…
- 外陰部痛治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vulvodynia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vulvodynia Treatment mar…
- 銃創治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gunshot Injuries Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.8% in the forecast period of 2020 to 2025 and will expected to reach USD 10 million by 2025, from USD 8 million in 2019. The Gunshot Injuries T…